Vice President (Commercial Operations), Exelixis
Gautam KolluGautam Kollu is VP of Commercial at Exelixis, where his team is charged with distribution, marketing and customer management efforts for cabozantinib, a novel oncology therapeutic. Most recently, he oversaw the strategic marketing initiatives for Exelixis’s portfolio of oncology compounds. Previously, Gautam worked at Genentech, where he led a launch team in the inception and build-out of a new neuro-oncology business. His team oversaw strategic planning and marketing initiatives from Phase I through FDA label negotiations and commercialization, growing the product to a market leading position. Earlier, he held several line management and staff roles within Genentech’s commercial function. Gautam also gained operating experience at Imclone Systems, Infinity Pharmaceuticals and Bionovo. He started his marketing career with Procter & Gamble and served as a strategy consultant with Bain & Company. He holds an MBA from The Wharton School at the University of Pennsylvania and a Bachelor’s degree in Chemical Engineering from the Indian Institute of Technology at Bombay.